VPS9D1 and acute lymphoblastic leukemia: All in all, these above data elucidated that VPS9D1-AS1 elevated GPX1 in ALL by sequestering miR-491-5p and miR-214-3p, which may provide promising biomarkers for the therapy of ALL patients.